AutoGenomics, which sells a molecular diagnostics system for genetic testing in clinical laboratories, has postponed its IPO, citing poor market conditions.
The Vista, CA-based company was founded in 1999 and booked $24 million in sales for the 12 months ended September 30, 2014. AGMX. AutoGenomics initially filed confidentially on 8/11/2014. Stifel, Canaccord Genuity and Cantor Fitzgerald were set to be the joint bookrunners on the deal.
